Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke "INSULINFARCT"


Phase 2/3 Results N/A

Eligibility Criteria

Inclusion Criteria

- Age over 18 years
- Carotid territory stroke
- MRI performed in the first five hours of stroke onset
- Baseline National Institutes of Health Stroke Scale (NIHSS) > 4 or < 26
- Time between MRI and treatment under one hour

Exclusion Criteria

- Pre-existing Modified Rankin Scale of three or higher
- Advanced or terminal illness with risk of death in the next 6 months, addiction